Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus (Q33393060)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

Elevated plasma level of HMGB1 is associated with disease activity and combined alterations with IFN-α and TNF-α in systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

26 July 2017

systemic lupus erythematosus

0 references

object named as

Zi-jiang Chen

7

0 references

author name string

Chun-yan Ma

1

1 reference

Europe PubMed Central

26 July 2017

Yu-lian Jiao

2

1 reference

Europe PubMed Central

26 July 2017

Jie Zhang

3

1 reference

Europe PubMed Central

26 July 2017

Qing-rui Yang

4

1 reference

Europe PubMed Central

26 July 2017

Zhi-fen Zhang

5

1 reference

Europe PubMed Central

26 July 2017

Ya-juan Shen

6

1 reference

Europe PubMed Central

26 July 2017

Yue-ran Zhao

8

1 reference

Europe PubMed Central

26 July 2017

publication date

1 December 2010

1 reference

Europe PubMed Central

26 July 2017

Rheumatology International

1 reference

Europe PubMed Central

26 July 2017

32

1 reference

Europe PubMed Central

26 July 2017

2

1 reference

Europe PubMed Central

26 July 2017

395-402

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/s00296-010-1636-6

0 references

Pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Induction of clinical autoimmune disease by therapeutic interferon-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

The role of tumor necrosis factor-alpha in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Expression of high mobility group box chromosomal protein 1 and its modulating effects on downstream cytokines in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

HMG1 and 2, and related 'architectural' DNA-binding proteins

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

HMG proteins: dynamic players in gene regulation and differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High mobility group box 1 protein interacts with multiple Toll-like receptors

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Requirement of HMGB1 and RAGE for the maturation of human plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Basic science for the clinician 42: handling the corpses: apoptosis, necrosis, nucleosomes and (quite possibly) the immunopathogenesis of SLE.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

The role of neutrophil apoptosis in juvenile-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

HMGB1 is an endogenous immune adjuvant released by necrotic cells

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Platelets prevent IFN-alpha/beta-induced lethal hemorrhage promoting CTL-dependent clearance of lymphocytic choriomeningitis virus.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Cross-regulation of TNF and IFN-alpha in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis

1 reference

https://api.crossref.org/works/10.1007%2FS00296-010-1636-6

21 January 2018

Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine production, serum levels and disease activity in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HMG-1 as a mediator of acute lung inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased extracellular levels of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in minor salivary glands of patients with Sjögren's syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/21120500

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-010-1636-6

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33393060&oldid=1615959848"